The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aclaris Therapeutics, Inc. | COM | 00461U105 | 5,534 | 2,153,265 | SH | SOLE | 2,153,265 | 0 | 0 | ||
| Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 6,266 | 883,720 | SH | SOLE | 883,720 | 0 | 0 | ||
| Aimmune Therapeutics, Inc. | COM | 00900T107 | 2,003 | 58,142 | SH | SOLE | 58,142 | 0 | 0 | ||
| Albireo Pharma, Inc. | COM | 01345P106 | 3,337 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| Allakos Inc | COM | 01671P100 | 15,666 | 192,334 | SH | SOLE | 192,334 | 0 | 0 | ||
| Allovir, Inc | COM | 019818103 | 2,504 | 91,057 | SH | SOLE | 91,057 | 0 | 0 | ||
| Alpine Immune Sciences Inc | COM | 02083G100 | 4,344 | 494,190 | SH | SOLE | 494,190 | 0 | 0 | ||
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | 105 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| Atreca Inc | COM | 04965G109 | 8,627 | 617,560 | SH | SOLE | 617,560 | 0 | 0 | ||
| BCTG Acquisition Corp | COM | 05492W103 | 5,180 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| BioNTech SE | SPONS ADS | 09075V102 | 879 | 12,700 | SH | SOLE | 12,700 | 0 | 0 | ||
| Catabasis Pharmaceuticals Inc | COM | 14875P206 | 1,857 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| CureVac N.V. | COM | N2451R105 | 17,241 | 370,385 | SH | SOLE | 370,385 | 0 | 0 | ||
| Equillium, Inc. | COM | 29446K106 | 6,199 | 1,074,285 | SH | SOLE | 1,074,285 | 0 | 0 | ||
| Forma Therapeutics Holdings, Inc. | COM | 34633R104 | 74,369 | 1,492,163 | SH | SOLE | 1,492,163 | 0 | 0 | ||
| Fulcrum Therapeutics, Inc. | COM | 359616109 | 2,332 | 294,118 | SH | SOLE | 294,118 | 0 | 0 | ||
| Genron Corporation | COM | 374163103 | 2,664 | 1,531,088 | SH | SOLE | 1,531,088 | 0 | 0 | ||
| Hookipa Pharma Inc | COM | 43906K100 | 1,104 | 116,602 | SH | SOLE | 116,602 | 0 | 0 | ||
| Intercept Pharmaceuticals Inc | COM | 45845P108 | 16,737 | 403,688 | SH | SOLE | 403,688 | 0 | 0 | ||
| Iveric Bio, Inc. | COM | 46583P102 | 19,009 | 3,370,478 | SH | SOLE | 3,370,478 | 0 | 0 | ||
| Kala Pharmaceuticals Inc | COM | 483119103 | 3,384 | 451,162 | SH | SOLE | 451,162 | 0 | 0 | ||
| KalVista Pharmaceuticals Inc | COM | 483497103 | 1,059 | 84,087 | SH | SOLE | 84,087 | 0 | 0 | ||
| NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 580 | 36,451 | SH | SOLE | 36,451 | 0 | 0 | ||
| Nkarta, Inc. | COM | 65487U108 | 61,163 | 2,034,703 | SH | SOLE | 2,034,703 | 0 | 0 | ||
| Novavax, Inc. | COM | 670002401 | 2,347 | 21,660 | SH | SOLE | 21,660 | 0 | 0 | ||
| Odonate Therapeutics Inc | COM | 676079106 | 10,951 | 815,421 | SH | SOLE | 815,421 | 0 | 0 | ||
| Panacea Acquisition Corp. | UNIT | 698102209 | 4,800 | 400,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| Rhythm Pharmaceuticals Inc | COM | 76243J105 | 5,089 | 234,846 | SH | SOLE | 234,846 | 0 | 0 | ||
| Rocket Pharmaceuticals Inc | COM | 77313F106 | 2,278 | 99,643 | SH | SOLE | 99,643 | 0 | 0 | ||
| Spero Therapeutics, Inc. | COM | 84833T103 | 1,786 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| Springworks Therapeutics Inc | COM | 85205L107 | 18,973 | 398,017 | SH | SOLE | 398,017 | 0 | 0 | ||
| Sutro BioPharma Inc | COM | 869367102 | 16,840 | 1,675,579 | SH | SOLE | 1,675,579 | 0 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q107 | 11,608 | 1,407,949 | SH | SOLE | 1,407,949 | 0 | 0 | ||
| Unum Therapeutics, Inc. | COM | 903214104 | 13,295 | 5,681,818 | SH | SOLE | 5,681,818 | 0 | 0 | ||
| Urovant Sciences Ltd | COM | G9381B108 | 1,471 | 157,480 | SH | SOLE | 157,480 | 0 | 0 | ||
| Verona Pharma PLC. | SPONS ADS | 925050106 | 6,933 | 1,111,112 | SH | SOLE | 1,111,112 | 0 | 0 | ||